Anzeige
Mehr »
Freitag, 27.03.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Drohnen: Entsteht hier der nächste Tech-Champion?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJ9 | ISIN: CA8475771033 | Ticker-Symbol: SD4
Frankfurt
27.03.26 | 08:00
0,875 Euro
-2,78 % -0,025
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPECTRAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
SPECTRAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8750,91522:57

Aktuelle News zur SPECTRAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSpectral Medical reports Q4 results1
DoSpectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update98TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
MiIs Spectral Medical a buy?2
DiSpectral Medical Inc: Spectral, Vantive release Tigris results in Lancet1
DiSpectral Medical Inc.: Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine226Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline...
► Artikel lesen
02.03.This analyst loves Spectral Medical2
26.02.Spectral Medical Inc: Spectral delays seeking premarket OK for PMX to mid-May3
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln
26.02.Stocks in Play: Spectral Medical Inc-
26.02.Spectral Medical Inc.: Spectral Medical Provides Update on PMA Submission Timing for PMX-20R116TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
07.11.25Spectral Medical GAAP EPS of -$0.11, revenue of $0.6M2
07.11.25Spectral Medical Inc.: Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update227PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE...
► Artikel lesen
30.09.25Spectral Medical Inc: Spectral Medical files base shelf prospectus2
29.09.25Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF1
25.08.25Spectral Medical Inc.: Spectral Medical Receives US$3 Million From Vantive390TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
13.08.25XFRA SD4: WIEDERAUFNAHME/RESUMPTION401FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
13.08.25XFRA SD4: AUSSETZUNG/SUSPENSION246DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSPECTRAL MEDICAL...
► Artikel lesen
12.08.25Spectral Medical Inc.: Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock263Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary...
► Artikel lesen
08.08.25Spectral Medical Inc.: Spectral Medical Announces Second Quarter and Provides Corporate Update268Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic...
► Artikel lesen
06.06.25Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders210TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
09.05.25Spectral Medical Inc.: Spectral Medical Announces First Quarter and Provides Corporate Update296Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...
► Artikel lesen
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1